# Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

> **NCT01511367** · PHASE3 · COMPLETED · sponsor: **Mundipharma Research Limited** · enrollment: 498 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Flutiform
- **DRUG:** Seretide
- **DRUG:** Flixotide

## Key facts

- **NCT ID:** NCT01511367
- **Lead sponsor:** Mundipharma Research Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-11
- **Target enrollment:** 498 (ESTIMATED)
- **Last updated:** 2018-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511367, "Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01511367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*